DANIELLA STAFFORD: Open Payments
NPI 1821354614 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 87 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,369 · 2025 $1,701
Food & beverage: $1,641Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $498 |
| Janssen Biotech, Inc. | 11 | $269 |
| Mallinckrodt Hospital Products Inc. | 12 | $226 |
| UCB, Inc. | 9 | $190 |
| Novartis Pharmaceuticals Corporation | 10 | $173 |
| Amgen Inc. | 4 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Lilly USA, LLC | 2 | $41 |
| PFIZER INC. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: RINVOQ, TREMFYA, ACTHAR, SKYRIZI, COSENTYX, Bimzelx, TALTZ, XELJANZ.
Industry payments across IN — which companies pay providers there.
